LifeSciences BC Blakes Breakfast Speaking Event on Medical Devices

This Breakfast Speaking Series is kindly presented by:

LifeSciences BC is pleased to announce Andre Marziali, Founder and CSO of Boreal Genomics Inc., and Bill Adams, CFO of Response Biomedical Corp., as our speakers for the May 14 Blakes Breakfast Speaking Event on Medical Devices.

Speaker Profiles:


Andre Marziali, Ph.D., P.Eng.
Director and Professor, Engineering Physics, University of British Columbia
Founder and CSO, Boreal Genomics Inc.

Dr. Marziali received his B.A.Sc. in Engineering Physics from UBC in 1989, and his PhD in Physics from Stanford University in 1994.
He subsequently worked for several years with Dr. Ron Davis, in the Stanford DNA Sequencing Technology Center, developing instruments for DNA sequencing and sample purification.
He returned to Canada in 1998, as an assistant professor at University of British Columbia in the Department of Physics and Astronomy, where he formed the Applied Biophysics Laboratory.
Shortly after his return to Canada, Dr. Marziali formed the GenomeBC Technology Development Platform, which he continues to lead as Co-Director.
In 2005 he was appointed Director of the Engineering Physics program at UBC, a position he continues to hold in parallel with research and commercialization activities.
In 2004, Dr. Marziali co-invented the concept of using synchronous mobility perturbations to create divergent velocity fields for selectively focusing nucleic acids.
This technology, termed SCODA, is the basis of a spin-off company, Boreal Genomics Inc. founded in 2007 by Dr. Marziali and colleagues to commercialize high performance instruments for DNA enrichment, and now commercializing a blood-based cancer test. In the last few years he has been awarded the 2003 Killam Prize for Excellence in Teaching, the 2004 BC Innovation Council – Young Innovator award, the 2005 Canadian Association of Physicists Medal for excellence in teaching, the 2007 Association for Lab Automation Innovation Award, and the 2011 Life Science BC Award for Innovation and Achievement.

Bill Adams
Chief Financial Officer
Response Biomedical Corp.

Mr. Adams has over 20 years of strategic financial management experience in both public and private companies.
He is the Chief Financial Officer of Response Biomedical Corp. and is a key member of the management team.
This team is successfully restructuring the company to return to significant sales growth in international markets and has recently entered into a significant R&D and supply collaboration agreement with a China based company.
From 1996 to 2006, Mr. Adams was the Chief Financial Officer of the TSX and NASDAQ listed bio-pharmaceutical company AnorMED Inc. from its start up, to IPO and through to its successful sale to a U.S.-based international bio-pharmaceutical company.
Mr. Adams has also held positions as CFO of a private forestry biotech company and a public technology company, and prior to that he was an audit manager with KPMG.
He is a Chartered Accountant and holds a Bachelor of Commerce Degree from the University of British Columbia.

Event Details

Date: Thursday, May 14

Time:
7:30 – 8:00 am – Registration and breakfast
8:00 - 9:00 am – Presentations
9:00 – 9:30 am – Networking opportunity

Location: Terminal City Club - 837 West Hastings Street, Vancouver

Registration:
LifeSciences BC members - $45 + GST
Non-members - $90 + GST

_______________________________________________________

For more information, please contact:

Sarah Wuertz
Events & Office Manager
LifeSciences BC
Tel: 604.669.9909 ext. 104
Email: swuertz@lifesciencesbc.ca